FLAM
APGE

First Light Asset Management’s Apogee Therapeutics APGE Stock Holding History

First Light Asset Management’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123M Buy
930,289
+353,605
+61% +$31.9M 7.51% 4
2026
Q1 		$48.5M Buy
576,684
+291,693
+102% +$21.2M 4.35% 6
2025
Q4 		$21.5M Buy
+284,991
New +$18M 1.64% 25

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

First Light Asset Management's APGE Position: Q2 2026 in Review

First Light Asset Management increased its Apogee Therapeutics (APGE) stake by 61% in Q2 2026, buying an estimated $31.9M and bringing the position to 930,289 shares worth $123M. The position accounts for 7.51% of the portfolio, ranked #4.

First Light Asset Management first reported a position in APGE in Q4 2025 and has held it in 3 quarters since. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • First Light Asset Management held 930,289 shares of Apogee Therapeutics worth $123M as of Q2 2026.
  • First Light Asset Management bought 353,605 Apogee Therapeutics shares in Q2 2026, an estimated $31.9M.
  • Apogee Therapeutics made up 7.51% of First Light Asset Management's portfolio in Q2 2026, its #4 holding.
  • First Light Asset Management first reported a position in Apogee Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on First Light Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.